These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31642578)

  • 21. Group sequential comparison of positive predictive value curves for correlated biomarker data.
    Ye X; Tang LL; Zhu X
    Stat Med; 2020 May; 39(12):1732-1745. PubMed ID: 32074391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
    Tang NS; Yu B; Tang ML
    BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determining sample size for a binary diagnostic test in the presence of verification bias.
    Shan G; Zhang H; Jiang T
    J Biopharm Stat; 2018; 28(6):1193-1202. PubMed ID: 29553878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A sample size planning approach that considers both statistical significance and clinical significance.
    Jia B; Lynn HS
    Trials; 2015 May; 16():213. PubMed ID: 25962998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matched-pair noninferiority trials using rate ratio: a comparison of current methods and sample size refinement.
    Tang ML
    Control Clin Trials; 2003 Aug; 24(4):364-77. PubMed ID: 12865032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors.
    Larsen MS; Juul RV; Kreilgaard M; Kristensen AT; Simonsson USH
    Eur J Pharm Sci; 2018 Oct; 123():531-538. PubMed ID: 30077714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blinded sample size re-estimation in crossover bioequivalence trials.
    Golkowski D; Friede T; Kieser M
    Pharm Stat; 2014; 13(3):157-62. PubMed ID: 24715672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of small sample size studies using nonparametric bootstrap test with pooled resampling method.
    Dwivedi AK; Mallawaarachchi I; Alvarado LA
    Stat Med; 2017 Jun; 36(14):2187-2205. PubMed ID: 28276584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marker Sequential Test (MaST) design.
    Freidlin B; Korn EL; Gray R
    Clin Trials; 2014 Feb; 11(1):19-27. PubMed ID: 24085774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sample size calculation for comparing two negative binomial rates.
    Zhu H; Lakkis H
    Stat Med; 2014 Feb; 33(3):376-87. PubMed ID: 24038204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exact and asymptotic tests under the sequential parallel comparison design.
    Lui KJ
    Pharm Stat; 2018 Nov; 17(6):835-845. PubMed ID: 30141237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficiency of study designs in diagnostic randomized clinical trials.
    Lu B; Gatsonis C
    Stat Med; 2013 Apr; 32(9):1451-66. PubMed ID: 23071073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of adaptive designs: efficiency evaluation.
    Menon S; Chang M
    J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flexible two-stage design with sample size reassessment for survival trials.
    Desseaux K; Porcher R
    Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and analysis of three-arm trials with negative binomially distributed endpoints.
    Mütze T; Munk A; Friede T
    Stat Med; 2016 Feb; 35(4):505-21. PubMed ID: 26388314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of constrained randomization for the design and analysis of group-randomized trials.
    Li F; Lokhnygina Y; Murray DM; Heagerty PJ; DeLong ER
    Stat Med; 2016 May; 35(10):1565-79. PubMed ID: 26598212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simple procedures for blinded sample size adjustment that do not affect the type I error rate.
    Kieser M; Friede T
    Stat Med; 2003 Dec; 22(23):3571-81. PubMed ID: 14652861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.